Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol
Jack H. Victory(National Cancer Institute), Jonathan M. Hernandez(National Institutes of Health), Emily C. Smith(National Cancer Institute), Changqing Xie(National Institutes of Health), Donna Mabry(National Institutes of Health), Cecilia Monge(National Institutes of Health), Tim F. Greten(National Institutes of Health), Jacob Lambdin(National Cancer Institute), Jeffrey Schlom(National Cancer Institute), Tracey Pu(National Cancer Institute), Jeremy L. Davis(University of Maryland, Baltimore), James L. Gulley(National Institutes of Health), Andrew M. Blakely(National Institutes of Health), Kathleen M. Smith(National Cancer Institute), Carrie E. Ryan(University at Buffalo, State University of New York), Cathleen E Hannah(National Cancer Institute), Ashley Rainey(National Cancer Institute), Amber Leila Sarvestani(National Institutes of Health), Alyssa V. Eade(National Cancer Institute), Carolina M. Larrain(National Cancer Institute), Bhavishya Ramamoorthy(National Institutes of Health), Lindsay Friedman(Public Health Ontario), Kenneth Luberice(National Cancer Institute)
Cited by 9
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817